Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3
- 1 April 2004
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 67 (8) , 1559-1567
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humansBlood, 2003
- Coordinated Signaling through Both G12/13 and Gi Pathways Is Sufficient to Activate GPIIb/IIIa in Human PlateletsJournal of Biological Chemistry, 2002
- Development of Platelet Inhibition by cAMP during MegakaryocytopoiesisJournal of Biological Chemistry, 2002
- α2A-Adrenergic Receptor Stimulation Potentiates Calcium Release in Platelets by Modulating cAMP LevelsJournal of Biological Chemistry, 2000
- cGMP inhibits IP3‐induced Ca2+ release in intact rat megakaryocytes via cGMP‐ and cAMP‐dependent protein kinasesThe Journal of Physiology, 1998
- Identification and Characterization of a Novel Family of Cyclic Nucleotide PhosphodiesterasesJournal of Biological Chemistry, 1998
- European Stroke Prevention Study-2 results: serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation?Trends in Pharmacological Sciences, 1998
- Inhibition of Platelet Adhesion to Collagen by cGMP-Elevating AgentsBiochemical and Biophysical Research Communications, 1997
- Prostacyclin and Sodium Nitroprusside Inhibit the Activity of the Platelet Inositol 1,4,5-Trisphosphate Receptor and Promote Its PhosphorylationJournal of Biological Chemistry, 1996
- Effect of thromboxane synthetase inhibitors on platelet function: Enhancement by inhibition of phosphodiesteraseThrombosis Research, 1982